Rockwell Medical, Inc.

RMTI Biotech & pharma

Manufactures hemodialysis concentrates for dialysis patients with end-stage kidney disease.

Jun 2026Revenue $69.4M/yrExpenses $73.9M/yr
No trend
Figures by year

When will Rockwell Medical be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $69.4M and expenses $73.9M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$69.3M$73.9M−$4.69M
Dec 2024$101M$101M$608K
Dec 2023$83.6M$90.3M−$6.67M
Dec 2022$72.8M$89.6M−$16.8M
Dec 2021$61.9M$92.3M−$30.3M
Dec 2020$62.2M$90.6M−$28.4M
Dec 2019$61.3M$95.8M−$34.5M
Dec 2018$63.4M$95.8M−$32.4M
Dec 2017$57.3M$83.2M−$25.9M